MedKoo Cat#: 593188 | Name: DSM502
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

DSM502 is a Dihydroorotate Dehydrogenase Inhibitor for the Treatment of Malaria. DSM502 showed in vivo efficacy . Overall, the pyrrole-based DHODH inhibitors provide an attractive alternative scaffold for the development of new antimalarial compounds.

Chemical Structure

DSM502
DSM502
CAS#2426616-55-7

Theoretical Analysis

MedKoo Cat#: 593188

Name: DSM502

CAS#: 2426616-55-7

Chemical Formula: C16H16F3N3O

Exact Mass: 23.1245

Molecular Weight: 323.32

Elemental Analysis: C, 59.44; H, 4.99; F, 17.63; N, 13.00; O, 4.95

Price and Availability

Size Price Availability Quantity
25mg USD 250.00 2 Weeks
50mg USD 450.00 2 Weeks
100mg USD 750.00 2 Weeks
200mg USD 1,250.00 2 Weeks
500mg USD 2,850.00 2 Weeks
1g USD 3,850.00 2 Weeks
2g USD 5,850.00 2 Weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
DSM502; DSM-502; DSM 502
IUPAC/Chemical Name
Cyclopropyl-3-methyl-4-((6-(trifluoromethyl)pyridin-3-yl)-methyl)-1H-pyrrole-2-carboxamide
InChi Key
AFOVOYRODSYDMK-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H16F3N3O/c1-9-11(8-21-14(9)15(23)22-12-3-4-12)6-10-2-5-13(20-7-10)16(17,18)19/h2,5,7-8,12,21H,3-4,6H2,1H3,(H,22,23)
SMILES Code
O=C(C1=C(C)C(CC2=CC=C(C(F)(F)F)N=C2)=CN1)NC3CC3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Malaria puts at risk nearly half the world's population and causes high mortality in sub-Saharan Africa, while drug resistance threatens current therapies. The pyrimidine biosynthetic enzyme dihydroorotate dehydrogenase (DHODH) is a validated target for malaria treatment based on our finding that triazolopyrimidine

Preparing Stock Solutions

The following data is based on the product molecular weight 323.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Kokkonda S, Deng X, White KL, et al. Lead Optimization of a Pyrrole-Based Dihydroorotate Dehydrogenase Inhibitor Series for the Treatment of Malaria [published online ahead of print, 2020 Apr 16]. J Med Chem. 2020;10.1021/acs.jmedchem.0c00311. doi:10.1021/acs.jmedchem.0c00311